Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TPEX/4161 stock hub

TPEX/4161 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4161is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4161

In the news

Latest news · TPEX/4161

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E18.9

P25 14.4P50 18P75 31.9

ROE7.4

P25 -16.2P50 0.3P75 9.8

ROIC5.9

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4161 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

TWD

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 1.3B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Isin	TW0004161005
Last refreshed	2026-05-10
Market cap	TWD 1.4B
Price	TWD 22.9
Price currency	TWD
Sector	Healthcare
Sic	3845
Symbol	tpex/4161
Website	https://www.bioptik.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.2%
EV Earnings	18.49x
EV/EBIT	19.72x
EV/EBITDA	13.23x
EV/FCF	32.24x
EV/Sales	1.57x
FCF yield	2.98%
P/B ratio	1.41x
P/E ratio	18.93x
P/S ratio	1.64x
PE Ratio10 Y	127.51x
PE Ratio3 Y	21.81x
PE Ratio5 Y	91.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.97%
EBITDA Margin	11.24%
FCF margin	4.88%
Gross margin	29.09%
Gross Profit	TWD 243.5M
Gross Profit Growth	-9.11%
Gross Profit Growth Q	-6.55%
Gross Profit Growth3 Y	11.12%
Gross Profit Growth5 Y	23.97%
Net Income	TWD 71.2M
Net Income Growth	-23.92%
Net Income Growth Q	-8.35%
Net Income Growth Years	0%
Net Income Growth3 Y	13.65%
Pretax Margin	10.19%
Profit Margin	8.5%
Profitable Years	5
ROA	2.73
Roa5y	2.67
ROCE	6.14
ROE	7.43
Roe5y	7.72
ROIC	5.93
Roic5y	5.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.69%
Cagr1y	-19.49%
Cagr3y	-9.2%
Cagr5y	-0.9%
Div CAGR3	-15.96%
Div CAGR5	-9.91%
EPS Growth	-23.9
EPS Growth Q	-7.97
EPS Growth Years	0
EPS Growth3 Y	12.81
FCF Growth	-71.63%
FCF Growth Q	-43.83%
FCF Growth3 Y	2.3%
OCF Growth	-62.23%
OCF Growth Q	-39.69%
OCF Growth10 Y	0.87%
OCF Growth3 Y	2.9%
OCF Growth5 Y	55.62%
Revenue Growth	-3.25x
Revenue Growth Q	3.52x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	2.93x
Revenue Growth5 Y	11.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.55
Assets	TWD 1.6B
Cash	TWD 448.4M
Current Assets	TWD 935.6M
Current Liabilities	TWD 484.4M
Debt	TWD 389.6M
Debt EBITDA	TWD 3.92
Debt Equity	TWD 0.4
Debt FCF	TWD 9.54
Equity	TWD 974.7M
Interest Coverage	8.77
Liabilities	TWD 597.1M
Long Term Assets	TWD 636.3M
Long Term Liabilities	TWD 112.7M
Net Cash	TWD 58.8M
Net Cash By Market Cap	TWD 4.29
Net Cash Growth	28.37%
Net Debt EBITDA	TWD -0.62
Net Debt Equity	TWD -0.06
Net Debt FCF	TWD -1.44
Tangible Book Value	TWD 966.6M
Tangible Book Value Per Share	TWD 16.16
WACC	4.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.93
Inventory Turnover	2.91
Net Working Capital	TWD 280M
Quick ratio	1.5
Working Capital	TWD 451.2M
Working Capital Turnover	TWD 1.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.13%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	TWD 0.7
Dividend Years	2
Dividend Yield	3.06%
Last Dividend	TWD 0.3
Payout Ratio	22.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-49.97%
1Y total return	-19.48%
200-day SMA	26.05
3Y total return	-25.15%
50-day SMA	24.66
50-day SMA vs 200-day SMA	50under200
5Y total return	-4.44%
All Time High	109.3
All Time High Change	-79.05%
All Time High Date	2014-07-01
All Time Low	16.34
All Time Low Change	40.11%
All Time Low Date	2011-12-20
ATR	0.5
Beta	0.27
Beta1y	0.37
Beta2y	0.46
Ch YTD	-8.22
High	23.2
High52	30.5
High52 Date	2025-09-24
High52ch	-24.92%
Low	22.9
Low52	22.9
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-7.12%
Price vs 200-day SMA	-12.08%
RSI	34.09
RSI Monthly	40.67
RSI Weekly	31.14
Sharpe ratio	-1x
Sortino ratio	-1.17
Total Return	3.19%
Tr YTD	-8.22
Tr1m	-5.57%
Tr1w	-1.08%
Tr3m	-10.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 66.7M
Operating Income Growth	-25.72
Operating Income Growth Q	-21.32
Operating Income Growth3 Y	19.12
Operating margin	7.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,487,305%
Net Borrowing	8,744,000
Shares Insiders	25.32%
Shares Out	59,808,000
Shares Qo Q	-0.68%
Shares Yo Y	-0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 32.7M
Average Volume	148,169.15x
Bv Per Share	16.21
CAPEX	TWD -19.2M
Ch10y	-55.64
Ch1m	-5.57
Ch1w	-1.08
Ch1y	-20.25
Ch3m	-10.72
Ch3y	-27.35
Ch5y	-9.43
Ch6m	-12.09
Change	-2.14%
Change From Open	-1.29
Close	23.4
Days Gap	-0.85
Depreciation Amortization	27,373,000
Dollar Volume	4,741,742.7
Earnings Date	2026-05-15
EBIT	TWD 66.7M
EBITDA	TWD 94.1M
EPS	TWD 1.21
F Score	5
FCF	TWD 40.8M
FCF EV Yield	3.1x
FCF Per Share	TWD 0.68
Financing CF	-4,072,000
Fiscal Year End	December
Founded	1,999
Graham Number	21.00617
Graham Upside	-8.27
Income Tax	TWD 15.5M
Investing CF	-37,275,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2025-12-31
Last Split Date	2025-08-20
Last Split Type	Forward
Lynch Fair Value	TWD 16.52
Lynch Upside	-27.88
Ma150	25.82
Ma150ch	-11.31%
Ma20	23.78
Ma20ch	-3.71%
Net CF	18,640,000
Next Earnings Date	2026-05-15
Open	23.2
P FCF Ratio	33.55
P OCF Ratio	22.83
Payment Date	2025-09-24
Position In Range	0
Ppne	495,837,000
Price Date	2026-05-08
Price EBITDA	TWD 14.55
Ptbv Ratio	1.42
Relative Volume	1.4x
Revenue	837,191,000x
SBC By Revenue	0.97x
Share Based Comp	8,151,000
Tax By Revenue	1.85x
Tax Rate	18.14%
Tr6m	-12.09%
Volume	207,063
Z Score	2.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4161 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.1%

$0.70 annual per share

Payout ratio

+22.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-9.9%

0 consecutive years of growth

Total shareholder yield

+3.2%

Dividend yield + buyback yield combined

Performance

TPEX/4161 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4161?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+25.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

TPEX/4161 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.1

Neutral momentum band

Price vs 200-day MA

-12.1%

50/200-day relationship not available

Beta (5Y)

0.27

Less volatile than the market

Sharpe ratio

-1.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4161

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4161 stock rating?

tpex/4161 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4161 analysis?

The full report lives at /stocks/tpex/4161/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4161?

The latest report frames tpex/4161 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4161 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.